Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Deferoxamine Mesylate

Deferoxamine Mesylate

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Deferoxamine Mesylate:

 BioPortfolio Logo
Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material 8th October, 2009 Sinobiopharma, Inc.
NANTONG CITY, China, Oct. 8 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma") (the "Company") is pleased to announce that the
ETHEX Corporation Issues Nationwide Voluntary Recall of Products 28th January, 2009 KV Pharmaceutical
ST. LOUIS, Jan. 28 /PRNewswire-FirstCall/ -- ETHEX Corporation, a subsidiary of KV Pharmaceutical (NYSE: KVa/KVb), is issuing, as previously disclosed by KV Pharmaceutical Company on January 26,

This page has been viewed 18 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Deferoxamine Mesylate across BioPortfolio, or for Deferoxamine Mesylate Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.